An interventional study of Thermo test pain and Pain questionnaires in REM Sleep Behavior Disorder (iRBD) and Narcolepsy Type 1, sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-01.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in REM Sleep Behavior Disorder with a site in France — 6 open to participants now, 6 under way, none of them phase 3. REM Sleep Behavior Disorder · France.
Among the 15 studies in REM Sleep Behavior Disorder with a site in France, this one is the 8th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2026, is one of 10 with no phase, and was the 14th registered.
101 studies on the registry are indexed under REM Sleep Behavior Disorder; 45 are open to participants now.
Browse REM Sleep Behavior Disorder studies →6 of the 15 studies in REM Sleep Behavior Disorder with a site in France are open now. Recruiting first, the newest first:
University Hospital, Clermont-Ferrand · Sites in France
Ages 45–80
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+ · Healthy volunteers
Queen Mary University of London · Sites in France, Spain, United Kingdom
Ages 50+
University Hospital, Toulouse · Sites in France, Germany, Spain and 1 more country
Ages 18+ · Healthy volunteers
University Hospital, Clermont-Ferrand · Sites in France
Ages 18–50
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 32 REM Sleep Behavior Disorder studies recruiting now, 18 (56%) set no upper age limit and 4 (13%) stop at 75 or younger; 4 take children under 18; 17 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 24 is below the median of 42 across 50 interventional studies indexed under REM Sleep Behavior Disorder.
Median enrollment 54 across the 10 interventional studies, 60 across the 5 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 9 most frequent:
University Hospital, Toulouse is the lead sponsor of 809 studies on the registry; 211 are open to participants now.
University Hospital, Toulouse has 2 studies filed under REM Sleep Behavior Disorder — fewer than ten, so there is no comparison to draw.
1 of the studies in REM Sleep Behavior Disorder with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07706829Queen Mary University of LondonArtificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study | 2027-09-30 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in REM Sleep Behavior Disorder with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, with over 12 million patients expected globally by 2040. The disease is currently diagnosed at the appearance of motor symptoms, but by then, over 60% of striatal dopaminergic neurons have already been destroyed. Prodromal symptoms such as idiopathic REM Sleep Behavior Disorder (iRBD), anosmia, mood disorders and constipation appear earlier and are listed as criteria for a prodromal PD diagnosis. Identifying early signs is critical to initiate neuroprotective treatments as early as possible. While pain is prevalent and highly disabling in early PD, no data are currently available on pain perception in iRBD patients, whose condition is of the main risk factor for PD development.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Control group:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who have an idiopathic REM sleep Behavior Disorder
Other: Thermo test pain · Other: Pain questionnaires · Other: No motors symptoms evaluations
patients who have an iRBD and who have type 1 narcolepsy
Other: Thermo test pain · Other: Pain questionnaires · Other: No motors symptoms evaluations
Patients will undergo a pain test, also called a thermotest, which consists of determining pain thresholds using a thermometer applied to the hand.
Patients will complete various questionnaires about pain
Patients will complete questionnaires
Comparison of the intensity of chronic pain between patients with iRBD and a control group of patients
Measuring the Visual Analog Scale (VAS) between patients with iRBD without diagnosis of PD and a control group of patients diagnosed with narcolepsy type 1 who present RBD (Rapid eye movement sleep behavior disorder).
Time frame: 2 hours after the inclusion
Describe semiological characteristics of pain in RBD patients
Description of characteristics of pain
Time frame: 2 hours after the inclusion
Compare the presence of chronic pain
Number of patients with chronic pain in both groups for at least 3 months.
Time frame: 2 hours after the inclusion
Assessing Pain Characteristics
Score obtained on pain questionnaires
Time frame: 2 hours after the inclusion
Assessment of thermal pain threshold and tolerance
Results of the quantitative sensory test (thermal thermotest) in both groups
Time frame: 2 hours after the inclusion
Assessment of correlations between the intensity of chronic pain
Correlation between Visual Analogue Scale (VAS) measurements and questionnaire responses
Time frame: 2 hours after the inclusion
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Aug 2026, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →